IL320996A - תרכובות מאפננות nmda שליליות ושיטות לשימוש בהן - Google Patents

תרכובות מאפננות nmda שליליות ושיטות לשימוש בהן

Info

Publication number
IL320996A
IL320996A IL320996A IL32099625A IL320996A IL 320996 A IL320996 A IL 320996A IL 320996 A IL320996 A IL 320996A IL 32099625 A IL32099625 A IL 32099625A IL 320996 A IL320996 A IL 320996A
Authority
IL
Israel
Prior art keywords
nmda
negative
methods
modulating compounds
modulating
Prior art date
Application number
IL320996A
Other languages
English (en)
Original Assignee
Sage Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sage Therapeutics Inc filed Critical Sage Therapeutics Inc
Publication of IL320996A publication Critical patent/IL320996A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL320996A 2022-11-21 2023-11-21 תרכובות מאפננות nmda שליליות ושיטות לשימוש בהן IL320996A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263427012P 2022-11-21 2022-11-21
PCT/US2023/080694 WO2024112759A1 (en) 2022-11-21 2023-11-21 Negative nmda-modulating compounds and methods of use thereof

Publications (1)

Publication Number Publication Date
IL320996A true IL320996A (he) 2025-07-01

Family

ID=89385897

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320996A IL320996A (he) 2022-11-21 2023-11-21 תרכובות מאפננות nmda שליליות ושיטות לשימוש בהן

Country Status (10)

Country Link
EP (1) EP4622987A1 (he)
JP (1) JP2025538551A (he)
KR (1) KR20250124139A (he)
CN (1) CN120882732A (he)
AR (1) AR131116A1 (he)
AU (1) AU2023385734A1 (he)
IL (1) IL320996A (he)
MX (1) MX2025005846A (he)
TW (1) TW202430133A (he)
WO (1) WO2024112759A1 (he)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
CN107936076B (zh) * 2011-09-08 2021-10-15 萨奇治疗股份有限公司 神经活性类固醇、组合物、及其用途
AU2014256229B2 (en) 2013-04-17 2018-10-04 Sage Therapeutics, Inc. 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
US11111266B2 (en) * 2016-10-18 2021-09-07 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
TW202143976A (zh) * 2020-03-18 2021-12-01 美商賽吉醫療公司 神經活性類固醇及其使用方法

Also Published As

Publication number Publication date
KR20250124139A (ko) 2025-08-19
WO2024112759A1 (en) 2024-05-30
AR131116A1 (es) 2025-02-19
MX2025005846A (es) 2025-08-01
EP4622987A1 (en) 2025-10-01
AU2023385734A1 (en) 2025-06-26
JP2025538551A (ja) 2025-11-28
CN120882732A (zh) 2025-10-31
TW202430133A (zh) 2024-08-01

Similar Documents

Publication Publication Date Title
IL314320A (he) תרכובות ושיטות לשימוש
IL312348A (he) מעכבי hif-2alpha ושיטות השימוש בו
IL299245A (he) חומרי קשירת lair-1 ושיטות השימוש בהם
IL316619A (he) מעכבי pi3kα ושיטות לשימוש בהם
IL316368A (he) נוגדנים אנטי- tl1a ושיטות לשימוש בהם
CA3262145A1 (en) AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE
ZA202208598B (en) Isoform-selective anti-tgf-beta antibodies and methods of use
CA3253801A1 (en) N6-ADENOSINE METHYL TRANSFERASE PROTAC AND METHODS FOR USE
IL314594A (he) תרכובות הטרוציקליות ושיטות לשימוש
CA3266793A1 (en) ANTI-B7H3 ANTIBODIES AND METHODS OF USE
IL317690A (he) נוגדנים אנטי- gpnmbושיטות לשימוש בהם
IL318694A (he) נוגדנים כנגד ccr8 ושיטות לשימוש בהם
IL315845A (he) נוגדנים אנטי-דקטין-1 ושיטות לשימוש בהם
IL323285A (he) נוגדנים נגד פוספוכולין ושיטות לשימוש בהם
CA3248844A1 (en) ANTI-B7-H3 COMPOUNDS AND METHODS OF USE
IL320996A (he) תרכובות מאפננות nmda שליליות ושיטות לשימוש בהן
IL299163A (he) תרכובות מקרוציקליות ושיטות לשימוש בהם
IL277528B (he) תרכובות קוטלות עשבים ושיטות לשימושיהן
CA3268418A1 (en) Multispecific Antibodies and Their Methods of Use
CA3259194A1 (en) ALDH-2 INHIBITING COMPOUNDS AND METHODS OF USE
CA3253413A1 (en) PYRIMIDOPYRIMIDONE COMPOUNDS AND THEIR METHODS OF USE
GB202315697D0 (en) Compounds and methods of use
IL314338A (he) תרכובות אנטי- b7-h3ושיטות לשימוש
GB202212937D0 (en) Compounds and methods of use
GB202119051D0 (en) Wingsail and method of use